Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development
Clinical investigators need to be wary of confounding and bias in real-world studies; here is what to look for and how to address it
Clinical investigators need to look out for confounding and bias associated with real-world data in randomized trials and observational studies used to produce real-world evidence (RWE) to assess the safety and efficacy of an intervention.
March 17, 2023
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Sophia Genetics partnering with Agilent Technologies to offer cancer analysis solution
Through the partnership, the Sophia DDM Platform will be integrated with Agilent’s research-use-only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit.
March 14, 2023
PerkinElmer completes divestiture of Applied, Food, and Enterprise Services businesses to New Mountain Capital
The company said that its Life Sciences and Diagnostics business resulting from the divestiture will focus on developing and delivering novel scientific breakthroughs.
March 13, 2023
Racial groups negatively impacted by exclusion from cancer research
Researchers are calling for greater inclusion of people with African ancestry in genomic research to improve prostate cancer outcome disparities.
March 10, 2023
Techcyte, Mayo Clinic to collaborate on algorithms for pathology platform
Techcyte’s Clinical Pathology AI Platform, which is CE-marked under IVDR and designated for research use only in the U.S., imports digital images of liquid-based samples from whole-slide scanners.
March 14, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Convert a smartphone into a fluorescent microscope for under $50
Researchers inexpensively convert smartphones into what they describe as “glowscope” microscopes, potentially enabling underserved students to observe living organisms.
March 9, 2023
Viz.ai platform to be used in patient enrollment for pulmonary embolism trial
Research institutions participating in the PE-TRACT trial will use the platform, Viz Recruit, to find, screen, and enroll trial candidates.
March 6, 2023
Artificial intelligence tool identifies current drugs for future pandemics
Researchers have created an algorithmic tool that calculates how to effectively repurpose current drugs to combat COVID-19 and future pandemics.
March 6, 2023
Illumina, Myriad Genetics provide U.S. access to HRD research test
The expanded partnership establishes a companion diagnostic (CDx) testing alliance for the pharmaceutical industry, which will enable more clinical research for gene-based, targeted therapies, the firms said.
March 6, 2023
Synergy Laboratories taps Sophia Genetics technology for cancer profiling
Synergy Oncology will pair its laboratory technologies with the Sophia DDM for Hereditary Cancers Solution for tumor profiling.
February 28, 2023
Agilent Technologies announces integrated on-deck thermal cycler for NGS platform
The on-deck thermal cycler enables the Bravo NGS platform to incorporate thermal cycling into an automated workflow for next-generation sequencing (NGS), end-point polymerase chain reaction (PCR), and cell-based applications.
February 27, 2023
Page 1 of 30
Next Page